Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Targeted proteomics of cerebrospinal fluid in treatment naïve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes ; volume:14 ; number:1 ; day:18 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.9.2024), 1-11, 12.2024

Creator
Rabin, Alexandra
Bello, Elisa
Kumar, Saurabh
Zeki, Dalia Abou
Afshari, Khashayar
Deshpande, Mugdha
Francis, Nimmy
Khalighinejad, Farnaz
Umeton, Raffaella
Radu, Irina
Qutab, Fatima
Kwong, Danny
Kurban, Mariana
Hemond, Christopher
Richmond, Jillian M.
Ionete, Carolina
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-024-67769-1
URN
urn:nbn:de:101:1-2412012108380.546033921793
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Rabin, Alexandra
  • Bello, Elisa
  • Kumar, Saurabh
  • Zeki, Dalia Abou
  • Afshari, Khashayar
  • Deshpande, Mugdha
  • Francis, Nimmy
  • Khalighinejad, Farnaz
  • Umeton, Raffaella
  • Radu, Irina
  • Qutab, Fatima
  • Kwong, Danny
  • Kurban, Mariana
  • Hemond, Christopher
  • Richmond, Jillian M.
  • Ionete, Carolina
  • SpringerLink (Online service)

Other Objects (12)

Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients

Towards optimised extracellular vesicle proteomics from cerebrospinal fluid

Towards optimised extracellular vesicle proteomics from cerebrospinal fluid

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations

Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury

Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury

Affinity proteomics identifies novel functional modules related to adhesion GPCRs

Affinity proteomics identifies novel functional modules related to adhesion GPCRs

Cerebrospinal Fluid Neurochemical Phenotypes in Vascular Dementias: Original Data and Mini-Review

Cerebrospinal Fluid Neurochemical Phenotypes in Vascular Dementias: Original Data and Mini-Review

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children

Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children

Quantitative proteomics analysis of Mycoplasma pneumoniae identifies potential macrolide resistance determinants

Quantitative proteomics analysis of Mycoplasma pneumoniae identifies potential macrolide resistance determinants

Spatial proteomics identifies JAKi as treatment for a lethal skin disease

Spatial proteomics identifies JAKi as treatment for a lethal skin disease

Urine proteomics identifies biomarkers for diabetic kidney disease at different stages

Urine proteomics identifies biomarkers for diabetic kidney disease at different stages

Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

Related objects